Curalife
1 known investors
Curalife offers natural, clinically tested supplements (such as Curalin and a GLP-1 satiety hormone activator) alongside online 1-on-1 support from registered dietitians to help people manage blood sugar, weight, and metabolic wellness. Its programs are consumer-facing and accepted by over 100 insurance plans.
Also known as CuraLife · Curalife Global
Investors · 1
Company profile
researched Aug 2026Curalife (styled CuraLife) is a direct-to-consumer metabolic wellness company that combines botanical dietary supplements with online, one-on-one guidance from registered dietitians. Its flagship product, Curalin, is a nine-ingredient capsule marketed for blood glucose support, with company materials citing clinical studies showing an average 18% HbA1c reduction and a trial in which participants saw roughly three times better results than placebo with no observed side effects. A second product, Curaslim, is positioned as a natural GLP-1 satiety-hormone activator for appetite control and weight management. The catalog also includes a Curalin/Curaslim bundle, a magnesium glycinate supplement and a CuraBox pill organizer, with U.S. list prices ranging from $20 for the organizer to $59.90 for Curalin.
Alongside products, Curalife operates a dietitian service in which members connect online with registered dietitians for blood sugar, weight-loss and general wellness goals. The company states it accepts more than 100 insurance plans and that most members pay $0 out of pocket. Company-reported outcomes for the service include 6% average weight loss, 60% of patients achieving at least 5% weight loss and 87% reporting better blood sugar management. Product formulation and scientific claims are overseen by a medical advisory board chaired by endocrinologist Prof. Itamar Raz and including Dr. Sarah Brewer, Dr. Sarah Kaplan, Dr. Michael Binder, Amir Malka, Prof. Zecharia Madar (Hebrew University) and Dr. Nancy Russell.
Founder and CEO Ron Elul has described the company's original focus as serving people with chronic conditions—particularly type 2 diabetes—through products, education, peer support and access to care, with co-founders named as Haviv, Ofer, Tomer, Alberto and Tal.
Founding story
Founder and CEO Ron Elul has said he began researching chronic disease after his father was diagnosed with type 2 diabetes, questioning why patients had to accept a permanent decline in quality of life. He founded CuraLife at a time when patients were beginning to take a more active role in managing their own health, with a stated vision of addressing chronic patients' needs from multiple angles including access to care, education and lifestyle guidance. Before Curalife, Elul founded startups in adtech, fintech and renewable energy.
Business model
Consumer-facing sales of dietary supplements, primarily through the company's own online stores, with a subscription model offering tiered discounts (10-25% off for one, three or six bottles), free lifetime shipping, loyalty points and a 60-day money-back guarantee. Curalife also monetizes a registered-dietitian telehealth service reimbursed through insurance plans, and lists a store locator for retail availability of its products.
Product revenue from one-time and subscription purchases of supplements (Curalin $59.90, Curaslim $49.90, bundle $104.00, magnesium glycinate $25.00, CuraBox $20.00; one-time Curalin purchases add $7.90 shipping), plus insurance-reimbursed dietitian consultations for which most members pay $0 out of pocket.
Traction
The company reports more than 70,000 clients and states that over 100,000 people across 14 countries use Curalife, with a blood sugar community of 100,000-plus members. Its Curalin product page cites over 3,000 reviews. Service-level figures cited include 6% average weight loss, 60% of patients achieving 5%+ weight loss and 87% reporting better blood sugar management, and acceptance of more than 100 insurance plans.
Latest developments
Curalife now markets itself as a metabolic wellness platform rather than a single-product supplement brand, having added Curaslim, a GLP-1-activation weight-loss supplement, and an insurance-billed registered dietitian service accepted by more than 100 plans, with most members paying nothing out of pocket.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Curalife positions itself as an early leader in clinical research among dietary supplements, stating that Curalin was the first supplement with clinical research published by the International Diabetes Federation and is one of few supplements with published clinical studies. Elul has framed the company as differentiated by an all-encompassing brand vision spanning supplements, education, peer support and digital health services for chronic patients.
Company materials emphasize published clinical research behind its supplements — including studies featured by the International Diabetes Federation — oversight by a medical advisory board of physicians and researchers, the pairing of supplements with insurance-covered registered dietitian support, and an explicit focus on the 50-plus consumer segment rather than younger D2C buyers.
Technology
The offering centers on botanical supplement formulations — Curalin's nine-ingredient blend described as combining Ayurvedic ingredients with modern science, and Curaslim positioned around GLP-1 satiety hormone activation — validated through clinical trials, alongside a digital platform for online one-on-one dietitian consultations, insurance coverage checks and subscription management.
Go-to-market
Direct-to-consumer e-commerce with subscription offers and a satisfaction guarantee, supported by customer testimonials and endorsements from physicians on its medical advisory board. The company also pursues retail placement via a store locator page, insurance-channel access for its dietitian service, and community building — describing itself as home to one of the largest blood sugar communities with over 100,000 members. Elul has described building credibility for nutraceuticals through patient-by-patient advocacy, clinical assets, and work with hundreds of medical professionals.
Adults managing blood sugar, pre-diabetes or type 2 diabetes, and people pursuing weight loss and general metabolic wellness. Elul has said that, unlike most D2C brands targeting younger consumers, Curalife focuses on the 50-plus market and has built distribution and marketing approaches for older consumers.
Geography
Curalife reports users in 14 countries. It runs a U.S.-facing store in dollars (curalife.com) that includes the insurance-covered dietitian service, and a global store (global.curalife.com) priced in pounds sterling offering supplements only. A store locator page directs customers to local retail stockists.
History
Curalife states it began in 2014 with a single focus on natural, research-backed support for healthy blood sugar, launching with one product, Curalin. It subsequently expanded into a broader metabolic wellness platform adding Curaslim, ancillary products such as magnesium glycinate and a pill organizer, and a registered-dietitian service billed through insurance. In earlier interviews, Elul described plans to launch a full suite of digital services using telemedicine to connect customers with doctors, nutritionists and coaches — a direction reflected in the current dietitian offering. The company also runs an international storefront (global.curalife.com) priced in pounds sterling, which offers supplements without the dietitian service.
Risks & controversies
Curalife's products are dietary supplements marketed with asterisked structure/function claims rather than approved drug indications, and the company has said it initially faced skepticism from both patients and healthcare professionals about the validity of nutraceuticals. Many reported outcome figures — client counts, average weight loss and blood sugar improvement percentages — are self-published by the company.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 4
launches, deals, and filingsCompany materials state Curalin became the first supplement with clinical research published by the International Diabetes Federation.
Curalife markets Curaslim, a natural supplement designed to support GLP-1 satiety hormone activation to reduce cravings and promote appetite control, priced at $49.90 in the U.S. store.
Curalife offers online 1-on-1 registered dietitian consultations for weight loss, blood sugar and wellness goals, accepted across 100+ insurance plans with most members paying $0 out of pocket.
Curalife states it began in 2014 focused on natural, research-backed blood sugar support, starting with a single product, Curalin.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 7
primary sources listed
- Curalifecuralife.com · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Curalife do?
- Curalife sells clinically tested natural supplements for blood sugar and weight with insurance-covered online dietitian support.
- Who are Curalife's investors?
- Curalife's investors include Catalyst Investments, L.P..